Results 21 to 30 of about 40,688 (146)

Mechanical Circulatory Support for Right Ventricular Failure

open access: yesCardiac Failure Review, 2022
Right ventricular (RV) failure is associated with significant morbidity and mortality, with in-hospital mortality rates estimated as high as 70–75%. RV failure may occur following cardiac surgery in conjunction with left ventricular failure, or may be ...
Ersilia M DeFilippis   +5 more
doaj   +1 more source

Hemostatic complications associated with ventricular assist devices

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2019
Hemostatic complications are common in patients with ventricular assist devices. The pathophysiologic mechanisms that lead to dysregulated hemostasis involve complex interactions between device surface, sheer stress, and blood flow. These factors lead to
Talal Hilal   +2 more
doaj   +1 more source

Long-Term renal function after implantation of continuous-flow left ventricular assist devices: A single center study

open access: yesInternational Journal of Cardiology: Heart & Vasculature, 2021
Background: Implantable continuous-flow left ventricular assist device (LVAD) improve renal function in advanced heart failure. However, the long-term effects of LVAD on renal function have not been investigated thoroughly.
Chie Bujo   +14 more
doaj   +1 more source

Successful heart transplantation after 4 years of bridging with HeartWare HVAD for left ventricular noncompaction in an 11-year-old boy with prohibitively high pulmonary vascular resistance

open access: yesAnnals of Pediatric Cardiology
End-stage heart failure due to left ventricular noncompaction (LVNC) poses unique challenges for ventricular assist device implantation, like inflow cannula obstruction due to trabeculations. We report a case of an 11-year-old boy with LVNC who underwent
Komarakshi R. Balakrishnan   +4 more
doaj   +1 more source

Interventional Microbubble Enhanced Sonothrombolysis on Left Ventricular Assist Devices

open access: yesAdvanced Science, 2022
The left ventricular assist device (LVAD) is often used in the treatment of heart failure. However, 4% to 9% implanted LVAD will have thrombosis problem in one year, which is fatal to the patient's life.
Xiaobing Zheng   +9 more
doaj   +1 more source

Value of nutritional indices in predicting survival free from pump replacement and driveline infections in centrifugal left ventricular assist devicesCentral MessagePerspective

open access: yesJTCVS Open
Objective: There is a paucity of data assessing the impact of nutritional status on outcomes in patients supported with the HeartMate 3 (HM3) left ventricular assist device (LVAD).
Fabian Jimenez Contreras, MD   +8 more
doaj   +1 more source

Non-Surgical Resolution of Inflow Cannula Obstruction of a Left Ventricular Assist Device: A Case Report

open access: yesJournal of Chest Surgery, 2021
A 55-year-old woman who had received an implantable left ventricular assist device 3 months earlier presented with dyspnea and a low-flow alarm of the device.
Yoonseo Lee   +5 more
doaj   +1 more source

Bariatric surgery in obese patients with ventricular assist devices

open access: yesBMC Research Notes, 2020
Objectives Patients with end-stage heart failure (ESHF) treated with ventricular assist devices (VADs) tend to gain weight, which may prevent them from receiving heart transplantation (HT) if their body mass index (BMI) reaches ≥ 35 kg/m2.
Adrian daSilva-deAbreu   +6 more
doaj   +1 more source

Considerations of valvular heart disease in children with ventricular assist devices

open access: yesFrontiers in Cardiovascular Medicine, 2023
Ventricular assist devices have become a valuable tool in the treatment of heart failure in children. The use of ventricular assist devices has decreased mortality in children with end-stage heart failure awaiting transplant.
Ming-Sing Si   +4 more
doaj   +1 more source

Current Trends in Implantable Left Ventricular Assist Devices

open access: yesCardiology Research and Practice, 2011
The shortage of appropriate donor organs and the expanding pool of patients waiting for heart transplantation have led to growing interest in alternative strategies, particularly in mechanical circulatory support.
Jens Garbade   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy